Geneseq Biosciences
banner
geneseq.bio
Geneseq Biosciences
@geneseq.bio
Geneseq Biosciences is an innovative biotechnology company based in Melbourne, Australia, focused on advancing cancer diagnostics through genomics. www.geneseq.com.au
August 1, 2025 at 3:20 AM
Kerri, 35, had a mole her GP dismissed, but it later itched and bled. Its removal showed melanoma. She urges trusting instincts and seeking second opinions, as GPs correctly diagnose melanomas just 29% of the time. #SkinCheck #MelanomaAwareness #TrustYourInstincts #EarlyDetectionMatters
July 21, 2025 at 10:47 PM
🩺 One Biopsy, Three Opinions, One Decision. Dr. Julia Marks got opinions from benign to melanoma. She asked, "Another opinion?", "Sub-specialist?", "Genomic tools?" With expert advice, she chose conservative treatment and is healthy. ✅
July 21, 2025 at 2:39 AM
Genomic profiling helps assess melanoma risk by analyzing microRNA expressions in lesions. Researchers create a scoring system for malignancy by identifying microRNA signatures, aiming to standardize diagnostics. #MelanomaAwareness #GenomicTesting #SkinHealth
July 16, 2025 at 11:02 PM
MicroRNAs influence gene activity and their disruption in melanoma aids cancer growth. This forms a molecular fingerprint separating melanoma from benign moles. Tracking these changes can enable earlier, precise diagnoses. #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine
July 14, 2025 at 11:06 PM
Genetic markers in moles unveil melanoma insights. Small molecules show severity; genomic tech detects RNA shifts, aiding early cancer detection. Result? Greater accuracy in diagnosis with 'molecular profiles.' #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine
July 13, 2025 at 11:42 PM
Diagnosing moles is tricky; misdiagnoses can cause anxiety or wrong treatment. Learn why it's complex and discover new tools.

Empower your health!

#MelanomaAwareness #DiagnosisMatters #KnowYourSkin
July 10, 2025 at 6:15 AM
Melanoma diagnosis varies greatly, showing tech limits. A 2017 study had only 25% agreement on atypical moles and 43% for early melanomas. Consider second opinions and stay informed on diagnostic tools for "early" or borderline lesions.

#Dermatology #MelanomaDiagnosis #Pathology #PatientSafety
July 9, 2025 at 2:11 AM
Diagnosing moles is tricky. Early melanoma diagnoses often vary, risking misdiagnoses. This may cause false reassurances or unnecessary surgeries. Researchers aim to improve detection. #MelanomaAwareness #DiagnosisMatters #KnowYourSkin
July 8, 2025 at 8:51 AM
Diagnosing moles is complex! Many early melanomas are misdiagnosed, leading to errors in treatment. We urgently need better detection tools. Join us this month to explore advancements in melanoma diagnosis.

#MelanomaAwareness #DiagnosisMatters #KnowYourSkin
July 7, 2025 at 11:45 PM
Great response from the media to our announcement this week. Melaseq is the first diagnostic test for melanoma that was entirely designed, validated and approved in Australia! 🇦🇺 ☀️ 🧪
December 7, 2024 at 2:06 AM
Australia’s first multi gene test to help diagnose melanoma early and accurately. #melaseq 🧪
December 1, 2024 at 2:43 AM